Charles Schwab Investment Management Inc. grew its position in shares of Owens & Minor, Inc. (NYSE:OMI – Free Report) by 13.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,305,043 shares of the company’s stock after buying an additional 276,807 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Owens & Minor were worth $30,127,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of OMI. Foundry Partners LLC bought a new position in Owens & Minor during the 3rd quarter worth approximately $5,238,000. Algert Global LLC lifted its holdings in Owens & Minor by 189.4% during the 3rd quarter. Algert Global LLC now owns 276,438 shares of the company’s stock worth $4,337,000 after buying an additional 180,922 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Owens & Minor by 374.2% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 223,074 shares of the company’s stock worth $3,500,000 after buying an additional 176,029 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Owens & Minor by 68.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after buying an additional 152,999 shares during the last quarter. Finally, Barclays PLC lifted its holdings in Owens & Minor by 354.8% during the 3rd quarter. Barclays PLC now owns 133,702 shares of the company’s stock worth $2,099,000 after buying an additional 104,305 shares during the last quarter. Institutional investors own 98.04% of the company’s stock.
Analyst Ratings Changes
Several analysts recently issued reports on OMI shares. UBS Group cut their price target on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. JPMorgan Chase & Co. cut their price target on Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a report on Monday, March 10th. Finally, Robert W. Baird raised their price target on Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Owens & Minor has an average rating of “Hold” and a consensus price target of $13.75.
Insider Activity
In other Owens & Minor news, major shareholder Coliseum Capital Management, L bought 1,738,511 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was acquired at an average price of $9.39 per share, with a total value of $16,324,618.29. Following the completion of the transaction, the insider now directly owns 9,469,698 shares in the company, valued at approximately $88,920,464.22. This represents a 22.49 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.59% of the stock is owned by insiders.
Owens & Minor Stock Up 1.6 %
Shares of OMI stock opened at $9.40 on Monday. Owens & Minor, Inc. has a 1 year low of $6.07 and a 1 year high of $28.35. The stock has a market cap of $726.04 million, a PE ratio of -14.46, a price-to-earnings-growth ratio of 0.20 and a beta of 0.61. The business’s fifty day moving average is $10.86 and its 200-day moving average is $12.78. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.
Owens & Minor (NYSE:OMI – Get Free Report) last issued its quarterly earnings results on Friday, February 28th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.02. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.70 billion for the quarter, compared to analysts’ expectations of $2.68 billion. During the same period last year, the firm earned $0.69 EPS. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. Equities analysts expect that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.
Owens & Minor announced that its board has initiated a share repurchase plan on Friday, February 28th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to reacquire up to 13.6% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.
Owens & Minor Profile
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Read More
- Five stocks we like better than Owens & Minor
- What Are Some of the Best Large-Cap Stocks to Buy?
- How to Build the Ultimate Everything ETF Portfolio
- What Are Trending Stocks? Trending Stocks Explained
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is a Death Cross in Stocks?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.